Pre-mRNA Processing Factor 31 (PRPF31) (Middle Region) Peptide
-
- Target See all PRPF31 products
- PRPF31 (Pre-mRNA Processing Factor 31 (PRPF31))
- Protein Region
- Middle Region
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Sequence
- VKQVKPLPAP LDGQRKKRGG RRYRKMKERL GLTEIRKQAN RMSFGEIEED
- Characteristics
- This is a synthetic peptide designed for use in combination with anti- PRPF31 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
- Application Notes
- Optimal working dilution should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- PRPF31 (Pre-mRNA Processing Factor 31 (PRPF31))
- Background
-
This gene encodes a component of the spliceosome complex and is one of several retinitis pigmentosa-causing genes. When the gene product is added to the spliceosome complex, activation occurs.
Alias Symbols: RP11, PRP31, SNRNP61, NY-BR-99
Protein Size: 278 - Gene ID
- 26121
- NCBI Accession
- NM_015629, NP_056444
-